Seattle genetics posts q4 loss per share of $0.14

Seattle genetics reports fourth quarter and full year 2019 financial results.q4 loss per share $0.14.q4 earnings per share estimate $-0.45 -- refinitiv ibes data.total revenues in the fourth quarter of $289.8 million versus $174.5 million.sees 2020 adcetris net product sales $675 million to $700 million.

SGEN Ratings Summary

SGEN Quant Ranking